edoc

Items where Author is "Obermann, E. C."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2012 | 2011 | 2010 | 2009
Number of items: 5.

2012

Plodinec, M. and Loparic, M. and Monnier, C. A. and Obermann, E. C. and Zanetti-Dallenbach, R. and Oertle, P. and Hyotyla, J. T. and Aebi, U. and Bentires-Alj, M. and Lim, R. Y. H. and Schoenenberger, C. -A.. (2012) The nanomechanical signature of breast cancer. Nature nanotechnology, Vol. 7, H. 11. pp. 757-765.

2011

Schmid, S. M. and Myrick, M. E. and Forrer, F. and Obermann, E. C. and Viehl, C. T. and Rochlitz, C. and Güth, U.. (2011) Sentinel lymph node biopsy in primary breast cancer : trust the radiolabeled colloid method and avoid unnecessary procedures. European journal of surgical oncology, Vol. 37, H. 3. pp. 211-216.

2010

Obermann, E. C. and Müller, N. and Rufle, A. and Menter, T. and Dirnhofer, S. and Tzankov, A.. (2010) [Clonal relationship of Hodgkin lymphoma and its recurrence]. Der Pathologe, Vol. 31, Suppl. 2. pp. 132-133.

2009

Obermann, E. C. and Csato, M. and Dirnhofer, S. and Tzankov, A.. (2009) Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment. Journal of clinical pathology : the journal of the Association of Clinical Pathologists, Vol. 62. pp. 754-756.

Obermann, E. C. and Csato, M. and Dirnhofer, S. and Tzankov, A.. (2009) BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma. Journal of clinical pathology : the journal of the Association of Clinical Pathologists, Vol. 62. pp. 903-907.

This list was generated on Thu Apr 18 10:19:58 2024 CEST.